These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6762744)

  • 41. Antibodies to pancreatic islet cells in insulin-dependent diabetics with coexistent autoimmune disease.
    MacCuish AC; Irvine WJ; Barnes EW; Duncan LJ
    Lancet; 1974 Dec; 2(7896):1529-31. PubMed ID: 4140978
    [No Abstract]   [Full Text] [Related]  

  • 42. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
    Pietropaolo M; Yu S; Libman IM; Pietropaolo SL; Riley K; LaPorte RE; Drash AL; Mazumdar S; Trucco M; Becker DJ
    Pediatr Diabetes; 2005 Dec; 6(4):184-92. PubMed ID: 16390386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immune complexes in type I diabetics with persistent islet cell antibodies.
    Irvine WJ; Di Mario U; Guy K; Borsey DQ
    J Clin Lab Immunol; 1980 Sep; 4(2):87-9. PubMed ID: 7003148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Islet cell antibodies in gestational diabetics.
    Ginsberg-Fellner F; Mark EM; Nechemias C; Hausknecht RU; Rubinstein P; Dobersen MJ; Notkins AL
    Lancet; 1980 Aug; 2(8190):362-3. PubMed ID: 6105489
    [No Abstract]   [Full Text] [Related]  

  • 45. [C-peptide, IgG-insulin antibodies, island cell antibodies and immune response genes in diabetes mellitus].
    Schernthaner G; Ludwig H; Mayr WR
    Verh Dtsch Ges Inn Med; 1978; (84):1200-4. PubMed ID: 105488
    [No Abstract]   [Full Text] [Related]  

  • 46. [Latent autoimmune diabetes in adults: an update].
    Zhou ZG; Li X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):630-4. PubMed ID: 14650175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Islet antibodies associated with pancreatic B-cell dysfunction at and 3 years after diagnosis of diabetes in subjects aged 35-64 years old: degree of impairment less severe than in those aged 0-34 years old.
    Berger B; Borg H; Fernlund P; Stenström G; Sundkvist G
    Diabet Med; 2006 Nov; 23(11):1180-5. PubMed ID: 17054592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin-dependent diabetes mellitus: the initial lesion.
    Cahill GF; McDevitt HO
    N Engl J Med; 1981 Jun; 304(24):1454-65. PubMed ID: 6785646
    [No Abstract]   [Full Text] [Related]  

  • 50. Incidence and significance of islet-cell autoantibodies in different types of diabetes mellitus.
    Del Prete GF; Betterle C; Padovan D; Erle G; Toffolo A; Bersahi G
    Diabetes; 1977 Oct; 26(10):909-15. PubMed ID: 332567
    [No Abstract]   [Full Text] [Related]  

  • 51. [Etiology and pathogenesis of insulin-dependent diabetes mellitus].
    Klöppel G; Clemens A
    Verh Dtsch Ges Pathol; 1996; 80():93-103. PubMed ID: 9065059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Islet-cell antibodies in Spanish diabetics.
    Pujol-Borrell R; Richart C; Martin C; Martinez-Vazquez JM; Bottazzo GF
    Lancet; 1978 Jul; 2(8083):268-9. PubMed ID: 79067
    [No Abstract]   [Full Text] [Related]  

  • 53. Complement-fixing islet-cell antibodies in type I diabetes and in susceptible patients with autoimmune diseases.
    Betterle C; Caretto A; Tiengo A; Trevisan A
    Lancet; 1980 Jun; 1(8183):1418-9. PubMed ID: 6104205
    [No Abstract]   [Full Text] [Related]  

  • 54. Islet-cell antibodies in diabetes mellitus.
    Lendrum R; Walker G; Cudworth AG; Theophanides C; Pyke DA; Bloom A; Gamble DR
    Lancet; 1976 Dec; 2(7998):1273-6. PubMed ID: 63747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent advances in diabetology: diabetic dermopathy, autoantibodies in the prediction of the development of type 1 diabetes, and islet cell transplantation and inhaled insulin as treatment for diabetes.
    Finucane KA; Archer CB
    Clin Exp Dermatol; 2006 Nov; 31(6):837-40. PubMed ID: 16907932
    [No Abstract]   [Full Text] [Related]  

  • 56. Circulating immune complexes in old people and in diabetics: correlation with autoantibodies.
    Delespesse G; Gausset P; Sarfati M; Dubi-Rucquoy M; Debisschop MJ; van Haelst L
    Clin Exp Immunol; 1980 Apr; 40(1):96-102. PubMed ID: 6993080
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Etiology and pathogenesis of type I diabetes].
    Ziegler AG
    Z Gesamte Inn Med; 1993 Mar; 48(3):100-7. PubMed ID: 8475631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Islet cell changes in the rat after injection of homogenized islets.
    Heydinger DK; Lacy PE
    Am J Surg; 1974 Nov; 128(5):608-11. PubMed ID: 4613193
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunity and autoimmunity in diabetes mellitus.
    Christy M; Deckert T; Nerup J
    Clin Endocrinol Metab; 1977 Jul; 6(2):305-32. PubMed ID: 330037
    [No Abstract]   [Full Text] [Related]  

  • 60. Is type 2 diabetes a chronic inflammatory/autoimmune disease?
    Syed MA; Barinas-Mitchell E; Pietropaolo SL; Zhang YJ; Henderson TS; Kelley DE; Korytkowski MT; Donahue RP; Tracy RP; Trucco M; Kuller LH; Pietropaolo M
    Diabetes Nutr Metab; 2002 Apr; 15(2):68-83. PubMed ID: 12059095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.